Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA003903 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA003903, RRID:AB_1858776
- Product name
- Anti-VSIG4
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human VSIG4, Gene description: V-set and immunoglobulin domain containing 4, Alternative Gene Names: Z39IG, Validated applications: IHC, Uniprot ID: Q9Y279, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases
Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma
Chong Y, Thiagarajan S, Tan Q, Lim H, Tan J, Hendrikson J, Ng G, Liu Y, Chong C, Guo W, Ngo N, Leow W, Loh T, Sam X, Lim T, Cai M, Seo C, Wong J, Soo K, Chia C, Shannon N, Ong C
Scientific Reports 2024;14(1)
Scientific Reports 2024;14(1)
Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma
Wang Y, Yan K, Lin J, Li J, Bi J
Frontiers in Genetics 2021;12
Frontiers in Genetics 2021;12
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma
Roh J, Jeon Y, Lee A, Lee S, Kim Y, Sung C, Park C, Hong J, Yoon D, Suh C, Huh J, Choi I, Park C
Oncotarget 2017;8(35):58122-58132
Oncotarget 2017;8(35):58122-58132
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human placenta and skeletal muscle tissues using HPA003903 antibody. Corresponding VSIG4 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
